Thyrocare Technologies has delivered a strong performance in the third quarter of FY25, reporting notable growth across key financial metrics. The company’s net profit surged by 24% year-on-year (YoY) to ₹19.1 crore, compared to ₹15.4 crore in the same quarter last year.
Key Financial Highlights:
- Net Profit: ₹19.1 crore, up 24% YoY from ₹15.4 crore
- Revenue: ₹165.9 crore, a 23.2% jump YoY from ₹134.7 crore
- EBITDA: ₹41.7 crore, a 32.4% rise YoY from ₹31.5 crore
- EBITDA Margin: 25.1%, compared to 23.4% YoY
Operational Excellence Boosts Growth
The company’s revenue growth of over 23% reflects robust demand for its diagnostic services. With a focus on operational efficiency, Thyrocare saw a significant 32.4% improvement in EBITDA, showcasing effective cost management and improved business efficiency.
The company’s EBITDA margin expansion to 25.1% indicates improved profitability, compared to the 23.4% margin recorded in the same period last year.
